AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit

By Brendan Pierson

Law360, New York (March 08, 2010, 12:25 PM ET) -- An indirect purchaser of Solvay Pharmaceuticals Inc.'s testosterone supplement AndroGel has asked for leave to amend a recently dismissed putative class action accusing the drugmaker of keeping generics rivals out of the market by paying them through patent settlements.

The lead indirect purchaser plaintiff — the Fraternal Order of Police, Fort Lauderdale Lodge 31, Insurance Trust Fund — filed a motion Friday in the U.S. District Court for the Northern District of Georgia, arguing it should be allowed to amend its complaint because it was never...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles